Profound Research LLC

Clinical research site in Royal Oak, Michigan

Part of Profound Research

As of July 2026, 2 paid clinical trials are recruiting at Profound Research LLC in Royal Oak, Michigan. Active studies at this site cover conditions such as PIK3CA Mutation, HER2- Negative Breast Cancer and Hormone Receptor Positive Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Profound Research LLC (2)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for PIK3CA Mutation

52 locations incl. Gilbert

Sponsor: Relay Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06982521·Phase 3·Recruiting·Listed May 2025

Apply to this trial

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for Oligometastatic Prostate Cancer (OMPC)

40 locations incl. Fayetteville

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18 - 100

Code: NCT05939414·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

More research sites in Royal Oak

Corewell Health William Beaumont University Hospital (37 trials)
Corewell Health Children's (17 trials)
William Beaumont Hospital (12 trials)
Cancer Care Associates PC (7 trials)
Comprehensive Medical Center PLLC (7 trials)
Hematology Oncology Consultants PC-Royal Oak (7 trials)
Oakland Colon Rectal Associates (7 trials)
Oakland Medical Group (7 trials)
Associated Retinal Consultants, P.C. (3 trials)
Beaumont Hospital, Royal Oak (3 trials)

Explore more

Paid clinical trials in Royal Oak, MI · Michigan clinical trials